So Much Potential, So Little Value15 Feb 2018 23:30
So Much Potential, So Little Share Value. A Buying Opportunity Here, Gang?
https://www.*************.com/views/34350/so-much-potential-so-little-share-value-a-buying-opportunity-here-gang
Hello, Shares Lovelies. It�s time to revisit a favourite penny share of mine. Though it�s not exactly repaid my loyalty in the last year. Nevertheless, I feel that, given its potential and support in 40 countries, the present lowly share price is unfair.
Feedback (FDBK) is a company which develops and provides software that helps doctors spot and interpret health problems that are not easily discernible. You cannot, I proffer, find many more worthwhile functions than that.
Within the last 12 months, the share sold for more than 5p. It�s now only 1.7p. But the City could now be waking up to the valuation being too conservative. Looking at the screens, I can see 1.7 million shares have been bought in a day with none sold. Consequently, the share price is up 12%.
I should imagine there is more to come. The company has just introduced its new CEO. David Crabb moves from a local software company which he turned around from a loss-maker into a profitable outfit. It was voted by the Sunday Times as one of the top 100 companies to work for.
Ok, that doesn�t prove Mr Crabb is the best business person in the world. But when a company which seems so useful to the planet cannot sustain reasonable increases in share value, perhaps you might put someone new at the top.
TexRAD, the company's patented �image texture analysis technology�, has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer. And get this: it is currently installed in over 40 of the world's leading research institutions across Europe, North America, Asia and Australasia. The stock is certainly worth more research, I would say.
Sign In
Follow the stocks
